nach oben

Neuropsychology Review

Erschienen in:

01.09.2007

The Effects of Tobacco Smoke and Nicotine on Cognition and the Brain

verfasst von: Gary E. Swan, Christina N. Lessov-Schlaggar

Erschienen in: Neuropsychology Review | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Tobacco smoke consists of thousands of compounds including nicotine. Many constituents have known toxicity to the brain, cardiovascular, and pulmonary systems. Nicotine, on the other hand, by virtue of its short-term actions on the cholinergic system, has positive effects on certain cognitive domains including working memory and executive function and may be, under certain conditions, neuroprotective. In this paper, we review recent literature, laboratory and epidemiologic, that describes the components of mainstream and sidestream tobacco smoke, including heavy metals and their toxicity, the effect of medicinal nicotine on the brain, and studies of the relationship between smoking and (1) preclinical brain changes including silent brain infarcts; white matter hyperintensities, and atrophy; (2) single measures of cognition; (3) cognitive decline over repeated measures; and (4) dementia. In most studies, exposure to smoke is associated with increased risk for negative preclinical and cognitive outcomes in younger people as well as in older adults. Potential mechanisms for smoke’s harmful effects include oxidative stress, inflammation, and atherosclerotic processes. Recent evidence implicates medicinal nicotine as potentially harmful to both neurodevelopment in children and to catalyzing processes underlying neuropathology in Alzheimer’s Disease. The reviewed evidence suggests caution with the use of medicinal nicotine in pregnant mothers and older adults at risk for certain neurological disease. Directions for future research in this area include the assessment of comorbidities (alcohol consumption, depression) that could confound the association between smoking and neurocognitive outcomes, the use of more specific measures of smoking behavior and cognition, the use of biomarkers to index exposure to smoke, and the assessment of cognition-related genotypes to better understand the role of interactions between smoking/nicotine and variation in genotype in determining susceptibility to the neurotoxic effects of smoking and the putative beneficial effects of medicinal nicotine.

Aggarwal, N. T., Bienias, J. L., Bennett, D. A., Wilson, R. S., Morris, M. C., Schneider, J. A., et al. (2006). The relation of cigarette smoking to incident Alzheimer’s disease in a biracial urban community population. Neuroepidemiology, 26, 140–146.PubMed

Alberg, A. J. (2002). The influence of cigarette smoking on circulating concentrations of antioxidant micronutrient micronutrients. Toxicology, 180, 121–137.PubMed

Aleman, A., Muller, M., de Haan, E. H. F., & van der Schouw, Y. T. (2005). Vascular risk factors and cognitive function in a sample of independently living men. Neurobiology of Aging, 26, 485–490.PubMed

Ambrose, J. A., & Barua, R. S. (2004). The pathophysiology of cigarette smoking and cardiovascular disease: An update. Journal of the American College of Cardiology, 43, 1731–1737.PubMed

Anbarasi, K., Kathirvel, G., Vani, G., Jayaraman, G., & Shyamala Devi, C. S. (2006). Cigarette smoking induces heat shock protein 70 kDa expression and apoptosis in rat brain: Modulation by bacoside A. Neuroscience, 138, 1127–1135.PubMed

Atkinson, H. H., Cesari, M., Kritchevsky, S. B., Penninx, B. W. J. H., Fried, L. P., & Guralnik, J. M., et al. (2005). Predictors of combined cognitive and physical decline. Journal of the American Geriatrics Society, 53, 1197–1202.PubMed

Bakhru, A., & Erlinger, T. P. (2005). Smoking cessation and cardiovascular disease risk factors: Results from the third national health and nutrition examination survey. PLoS Medicine, 2, 528–536.

Barnes, D. E., Alexopoulos, G. S., Lopez, O. L., Williamson, J. D., & Yaffe, K. (2006). Depressive symptoms and vascular disease and mild cognitive impairment: Findings from the cardiovascular health study. Archives of General Psychiatry, 63, 273–280.PubMed

Barnett, J. H., Heron, J., Ring, S. M., Golding, J., Goldman, D., & Xu, K., et al. (2007). Gender-specific effects of the catecol-O-methyltransferase Val158Met polymorphism on cognitive function in children. American Journal of Psychiatry, 164, 142–149.PubMed

Barnoya, J., & Glantz, S. A. (2005). Cardiovascular effects of secondhand smoke: Nearly as large as smoking. Circulation, 111, 2684–2698.PubMed

Bernhard, D., Rossmann, A., Wick, G. & Sampson, E. J. (2005). Metals in cigarette smoke. IUBMB Life, 57, 805–809.PubMed

Bhargava, D., Weiner, M. F., Hynan, L. S., Diaz-Arrastia, R., & Lipton, A. M. (2006).Vascular disease risk factors, rate of progression and survival in Alzheimer’s disease. Journal of Geriatric Psychiatry and Neurology, 19, 78–82.PubMed

Bowirrat, A., Friedland, R. P., Farrer, L., Baldwin, C., & Korczyn, A. (2002). Genetic and environmental risk factors for Alzheimer’s disease in Israeli Arabs. Journal of Molecular Neuroscience, 19, 39–45.

Brody, A. L. (2006). Functional brain imaging of tobacco use and dependence. Journal of Psychiatric Research, 40, 404–418.PubMed

Brody, A. L., Mandelkern, M. A., Jarvik, M. E., Lee, G. S., Smith, E. C., Huang, J. C., et al. (2004). Differences between smokers and non-smokers and regional gray matter volumes and densities. Biological Psychiatry, 55, 77–84.PubMed

Buccafusco, J. J., Shuster, L. C., & Terry, A. V., Jr. (2007). Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine. Neuroscience Letters, 13, 68–71.

Buccafusco, J. J., & Terry, A. V., Jr. (2003). The potential role of cotinine in the cognitive and neuroprotective actions of nicotine. Life Sciences, 72, 2931–2942.PubMed

Bursi, F., Rocca, W. A., Killian, J. M., Weston, S. A., Knopman, D. S., Jacobsen, S. J., et al. (2005). Heart disease and dementia: A population-based study. American Journal of Epidemiology, 163, 135–141.PubMed

Buschke, H., & Fuld, P. A. (1974). Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology, 24, 1019–1025.PubMed

Butterfield, D. A., Perluigi, M., & Sultana, R. (2006). Oxidative stress in Alzheimer’s disease brain: New insights from redox proteomics. European Journal of Pharmacology, 545, 39–50.PubMed

Casserly, I., & Topol, E. (2004). Convergence of atherosclerosis and Alzheimer’s disease: Inflammation, cholesterol, and misfolded proteins. Lancet, 363, 1139–1146.PubMed

Checkoway, H., Powers, K., Smith-Weller, T., Franklin, G. M., Longstreth, W. T., Jr., & Swanson, P. D. (2002). Parkinson’s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. American Journal of Epidemiology, 155, 732–738.PubMed

Chong, Z. Z., Li, F., & Maiese, K. (2005). Stress in the brain: Novel cellular mechanisms of injury linked to Alzheimer’s disease. Brain Research Reviews, 49, 1–21.PubMed

de Frias, C. M., Annerbrink, K., Westberg, L., Eriksson, E., Adolfsson, R., & Nilsson, L.-G. (2005). Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults. Journal of Cognitive Neuroscience, 17, 1018–1025.PubMed

de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Bulletin, 76, 135–157.

de Quervain, D. J., & Papassotiropoulos, A. (2006). Identification of a genetic cluster influencing memory performance and hippocampal activity in humans. Proceedings of the National Academy of Sciences of the United States of America, 103, 4270–4274.PubMed

Dierker, L. C., Avenevoli, S., Stolar, M., & Merikangas, K. R. (2002). Smoking and depression: An examination of mechanisms of comorbidity. American Journal of Psychiatry, 159, 947–953.PubMed

Durazzo, T. C., Cardenas, V. A., Studholme, C., Weiner, M. W., & Meyerhoff, D. J. (2007). Non-treatment-seeking heavy drinkers: Effects of chronic cigarette smoking on brain structure. Drug and Alcohol Dependence, 87, 76–82.PubMed

Durazzo, T. C., Gazdzinski, S., Banys, P., & Meyerhoff, D. J. (2004). Cigarette smoking exacerbates chronic alcohol-induced brain damage: A preliminary metabolite imaging study. Alcoholism, Clinical and Experimental Research, 28, 1849–1860.PubMed

Durazzo, T. C., Gazdzinski, S., & Meyerhoff, D. J. (2007). The neurobiological and neurocognitive consequences of chronic cigarette smoking in alcohol use disorders. Alcohol and Alcoholism, 42, 174–185.PubMed

Durazzo, T. C., Rothlind, J. C., Weiner, M. W., & Meyerhoff, D. J. (2005). Effects of chronic cigarette smoking on neuropsychological test performance in heavy social drinkers. In Paper presented at the 28th Annual Meeting of the Research Society on Alcoholism, Santa Barbara, CA.

Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell, 112, 257–269.PubMed

Ernst, M., Heishman, S. J., Spurgeon, L., & London, E. D. (2001). Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology, 25, 313–319.PubMed

Foulds, J., Stapleton, J., Swettenham, J., Bell, N., McSorley, K., Russell, M. A. (1996). Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology, 127, 31–38.PubMed

Fowles, J., & Dybing, E. (2003). Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tobacco Control, 12, 424–430.PubMed

French, K. L., Granholm, A. C., Moore, A. B., Nelson, M. E., & Bimonte-Nelson, H. A. (2006). Chronic nicotine improves working and reference memory performance and reduces hippocampal NGF in aged female rats. Behavior and Brain Research, 169, 256–262.

Fried, P. A., Watkinson, B., & Gray, R. (2003). Differential effects on cognitive functioning in 13- to 16-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicology and Teratology, 25, 427–436.PubMed

Fried, P. A., Watkinson, B., & Siegel, L. S. (1997). Reading and language in 9- to 12-year olds prenatally exposed to cigarettes and marijuana. Neurotoxicology and Teratology, 19, 171–183.PubMed

Galanis, D. J., Petrovich, H., Launer, L., Harris, T. B., Foley, D. J., & White, L. R. (1997). Smoking history in middle-aged and subsequent cognitive performance in elderly Japanese-American men. The Honolulu–Asia Aging Study. American Journal of Epidemiology, 145, 507–515.PubMed

Gallinat, J., Lang, U. E., Jacobsen, L. K., Bajbouj, M., Kalus, P., & von Haebler, D., et al. (2007). Abnormal hippocampal neurochemistry in smokers: Evidence from proton magnetic resonance spectroscopy at 3T. Journal of Clinical Psychopharmacology, 27, 80–84.PubMed

Gazdzinski, S., Durazzo, T., Jahng, G. H., Ezekiel, F., Banys, P., & Meyerhoff, D. (2006). Effects of chronic alcohol dependence and chronic cigarette smoking on cerebral perfusion: A preliminary magnetic resonance study. Alcoholism, Clinical and Experimental Research, 30, 947–958.PubMed

Gazdzinski, S., Durazzo, T. C., Studholme, C., Song, E., Banys, P., & Meyerhoff, D. J. (2005). Quantitative brain MRI in alcohol dependence: Preliminary evidence for effects of concurrent chronic cigarette smoking on regional brain volumes. Alcoholism, Clinical and Experimental Research, 29, 1484–1495.PubMed

Gentry-Nielsen, M. J., vander Top, E., Snitily, M. U., Casey, C. A., & Preheim, L. C. (2004). A rat model to determine the biomedical consequences of concurrent ethanol ingestion and cigarette smoke exposure. Alcoholism, Clinical and Experimental Research, 28, 1120–1128.PubMed

Ginzel, K. H., Maritz, G. S., Marks, D. F., Neuberger, M., Pauly, J. R., Polito, J. R., et al. (2007). Critical review: Nicotine for the fetus, the infant and the adolescent? Journal of Health Psychology, 12, 215–224.PubMed

Gold, G., Giannakopoulos, P., Montes-Paixao, C., Herrmann, F. R., Mulligan, R., Michel, J. P., et al. (1997). Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology, 49, 690–694.PubMed

Gorelick, P. B. (2004). Risk factors for vascular dementia and Alzheimer’s disease. Stroke, 35, 2620–2622.PubMed

Harris, S. E., Wright, A. F., Hayward, C., Starr, J. M., Whalley, L. J., & Deary, I. J. (2005). The functional COMT polymorphism, Val158Met, is associated with logical memory and the personality trait intellect/imagination in a cohort of healthy 79 year olds. Neuroscience Letters, 385, 1–6.PubMed

Hasenfrantz, M., Pfiffner, D., Pellaud, K., & Battig, K. (1989). Postlunch smoking for pleasure seeking or arousal maintenance? Pharmacology Biochemistry and Behavior, 34, 631–639.

Heishman, S. J., & Henningfield, J. E. (2000). Tolerance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers. Psychopharmacology (Berlin), 152, 321–333.

Heishman, S. J., Snyder, F. R., & Henningfield, J. E. (1993). Performance, subject, and physiological effects of nicotine in nonsmokers. Drug and Alcohol Dependence, 34, 11–18.PubMed

Hellström-Lindahl, E., Court, J., Keverne, J., Svedberg, M., Lee, M., Marutle, A., et al. (2004). Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice. European Journal of Neuroscience, 19, 2703–2710.PubMed

Hindmarch, I., Kerr, J. S., & Sherwood, N. (1990). Effects of nicotine gum on psychomotor performance in smokers and nonsmokers. Psychopharmacology, 100, 535–541.PubMed

Hirvonen, M., Laakso, A., Nagren, K., Rinne, J. O., Pohjalainen, T., & Hietala, J. (2004). C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Molecular Psychiatry, 9, 1060–1066, 10:889 (Erratum).

Howard, G., Wagenknecht, L. E., Cai, J., Cooper, L., Kraut, M. A., & Toole, J. F. (1998). Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke, 29, 913–917.PubMed

Hulse, G. K., Lautenschlager, N. T., Tait, R. J., & Almeida, O. P. (2005). Dementia associated with alcohol and other drug use. International Psychogeriatrics, 17(Supplement), S109–S127.PubMed

Huentelman, M. J., Papassotiropoulos, A., Craig, D. W., Hoerndli, F. J., Pearson, J. V., Huynh, K. D., et al. (2007). Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance. Human Molecular Genetics, 16, 1469–1477.PubMed

Hughes, J. R., Hatsukami, D. K., Mitchell, J. E., & Dahlgren, L. A. (1986). Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry, 143, 993–997.PubMed

Hurt, R. D., Eberman, K. M., Croghan, I. T., Offord, K. P., Davis, L. J., Jr, Morse, R. M., et al. (1994). Nicotine dependence treatment during inpatient treatment for other addictions: A prospective intervention trial. Alcoholism, Clinical and Experimental Research, 18, 867–872.PubMed

Ilan, A. B., & Polich, J. (2001). Tobacco smoking and event-related brain potentials in a Stroop task. International Journal of Psychophysiology, 40, 109–118.PubMed

Jacobsen, L. K., Krystal, J. H., Menci, W. E., Westerveld, M., Frost, S. J., & Pugh, K. R. (2005). Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biological Psychiatry, 57, 56–66.PubMed

Jacobsen, L. K., Pugh, K. R., Mencl, W. E., & Gelernter, J. (2006). C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. Psychopharmacology (Berlin), 188, 530–540.

Jacobsen, L. K., Slotkin, T. A., Menci, W. E., Frost, S. J., & Pugh, K. R. (2007). Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention. Neuropsychopharmacology, 21, 1–12, March.

Jacobsen, L. K., Slotkin, T. A., Westerveld, M., Menci, W. E., Pugh, K. R. (2006). Visuospatial memory deficits emerging during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking. Neuropsychopharmacology, 31, 1550–1561.PubMed

Juan, D., Zhou, D. H., Li, J., Wang, J. Y., Gao, C., & Chen, M. (2004). A 2-year follow-up study of cigarette smoking and risk of dementia. European Journal of Neurology, 11, 277–282.PubMed

Kalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., et al. (2000). Metabolic cardiovascular syndrome and risk of dementia in Japanese American elderly man: The Honolulu Asia Aging study. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 2255–2260.PubMed

Kang, J. H., Logroscino, G., De Vivo, I., Hynter, D., & Grodstein, F. (2005). Apolipoprotein E, and cardiovascular disease and cognitive function in aging women. Neurobiology of Aging, 26, 475–484.PubMed

Keenan, R. M., Hatsukami, D. K., & Anton, D. J. (1989). The effects of short-term smokeless tobacco deprivation on performance. Psychopharmacology, 98, 126–130.PubMed

Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66, 17–31.PubMed

Kin, T., Yamano, S., Sakurai, R., Kajitani, M., Okahashi, Y., Nishiura, N., et al. (2007). Carotid atherosclerosis is associated with brain atrophy in Japanese elders. Gerontology, 53, 1–6.PubMed

Knopman, D., Boland, L. L., Mosley, T., Howard, G., Liao, D., Szklo, M., et al. (2001). Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology, 56, 42–48.PubMed

Kode, A., Yang, S.-R., & Rahman, I. (2006). Differential effects of cigarette smoke on oxidative stress and pro-inflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respiratory Research, 7, 1–20.

Koschack, J., & Irle, E. (2005). Small hippocampal size and cognitively normal subjects with coronary artery disease. Neurobiology of Aging, 26, 865–871.PubMed

Kubota, K., Matsuzawa, T., Fujiwara, T., Yamaguchi, T., Ito, K., Watanabe, H., et al. (1987). Age related brain atrophy enhanced by smoking: A quantitative study with computed tomography. Tohoku Journal of Experimental Medicine, 153, 303–311.PubMed

Kumari, V., Gray, J. A., Ffytche, D. H., Mitterschiffthaler, M. T., Das, M., Zacariah, E., et al. (2003). Cognitive effects of nicotine in humans: An fMRI study. NeuroImage, 19, 1002–1013.PubMed

Landers, D. M., Crews, D. J., Boutcher, S. H., Skinner, J. S., & Gustafsen, S. (1992). The effects of smokeless tobacco on performance and psychophysiological response. Medical Science and Sports Exercise, 24, 895–903.

Le Houezec, J., Halliday, R., Benowitz, N. L., Callaway, E., Naylor, H., & Herzig, K. (1994). A low dose of subcutaneous nicotine improved information processing in non-smokers. Psychopharmacology, 114, 628–634.PubMed

Lee, P. N. (1994). Smoking and Alzheimer’s disease: A review of the epidemiologic literature. Neuroepidemiology, 13, 131–144.PubMed

Leonard, S., & Adams, C. E. (2006). Smoking cessation and schizophrenia. American Journal of Psychiatry, 163, 1877.PubMed

Liu, G., Huang, W., Moir, R. D., Vanderburg, C. R., Lai, B., Peng, Z., et al. (2006). Metal exposure and Alzheimer’s pathogenesis. Journal of Structural Biology, 155, 45–51.PubMed

Loeb, C., & Meyer, J. S. (1996). Vascular dementia: Still a debatable entity? Journal of Neurological Science, 143, 31–40.

Longstreth, W. T., Jr., Arnold, A. M., Beauchamp, N. J., Manolio, T. A., Lefkowitz, D., Jungreis, C., et al. (2005). Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: The Cardiovascular Health Study. Stroke, 36, 56–61.PubMed

Longstreth, W. T., Jr., Diehr, P., Manolio, T. A., Beauchamp, N. J., Jungreis, C. A., Lefkowitz, D., et al. (2001). Cluster analysis and patterns of findings on cranial magnetic resonance imaging of the elderly: The Cardiovascular Health Study. Archives of Neurology, 58, 635–640.PubMed

Lopez, E., Arce, C., Oset-Gasque, M. J., Canadas, S., & Gonzalez, M. P. (2006). Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. Free Radicals in Biology and Medicine, 40, 940–951.

Luchsinger, J., Reitz, C., Honig, L. S., Tang, M.-X., Shea, S., & Mayeux, R. (2005). Aggregation of vascular risk factors and risk of incident Alzheimer’s disease. Neurology, 65, 545–551.PubMed

Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P., et al. (1998). Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neuroscience, 1, 69–73.PubMed

Manna, S. K., Rangasamy, T., Wise, K., Sarkar, S., Shishodia, S., Biswal, S., et al. (2006). Long term environmental tobacco smoke activates nuclear transcription factor-kappa B, activator protein-1, and stress responsive kinases in mouse brain. Biochemistry and Pharmacology, 71, 1602–1609.

Mariani, E., Polidori, M. C., Cherubini, A., & Mecocci, P. (2005). Oxidative stress in brain aging, and degenerative and vascular diseases: An overview. Journal of Chromatography B, 27, 65–75.

Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3, 2011–2030.

Mazza, M., Pomponi, M., Janiri, L., Bria, P., & Mazza, S. (2007). Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. Progress in Neuropsychopharmacology and Biological Psychiatry, 31, 12–26.

McCartney, J. S., Fried, P. A., & Watkinson, B. (1994). Central auditory processing in school-age children prenatally exposed to cigarette smoke. Neurotoxicology and Teratology, 16, 269–276.PubMed

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, & E. M. (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology, 34, 939–944.PubMed

Meyer, J. S., Rauch, G. M., Crawford, K., Rauch, R. A., Konno, S., Akiyama, H., et al. (1999). Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. International Journal of Geriatric Psychiatry, 14, 1050–1061.PubMed

Meyer, J. S., Rauch, G., Rauch, R. A., & Haque, A. (2000). Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiology of Aging, 21, 161–169.PubMed

Muller, M., Grobbee, D. E., Aleman, A., Bots, M., & van der Schouw, Y. T. (2007). Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis, 190, 143–149.PubMed

Murray, A. D., Staff, R. T., Shenkin, S. D., Deary, I. J., Starr, J. M., & Whalley, L. J. (2005). Brain white matter hyper intensities: Relative importance of vascular risk factors and non-demented elderly people. Radiology, 237, 251–257.PubMed

Newman, A. B., Fitzpatrick, A. L., Lopez, O., Jackson, S., Lyketsos, C., Jagust, W., et al. (2005). Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. Journal of the American Geriatrics Society, 53, 1257–1258.

Nordberg, A., Hellström-Lindahl, E., Lee, M., Johnson, M., Mousavi, M., Hall, R., et al. (2002). Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer’s disease (APPsw). Journal of Neurochemistry, 81, 655–658.PubMed

Oddo, S., Caccamo, A., Green, K. M., Liang, K., Tran, L., Chen, Y., et al. (2005). Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 102, 3046–3051.PubMed

O’Hara, R., Miller, E., Liao, C.-P., Way, N., Lin, X., & Hallmayer, J. (2006). COMT genotype, gender and cognition in community-dwelling older adults. Neuroscience Letters, 409, 205–209.PubMed

Ott, A., Andersen, K., Dewey, M. E., Letenneur, L., Brayne, C., Copeland, J. R. M., et al. (2004). Effect of smoking on global cognitive function in non-demented elderly. Neurology, 62, 920–924.PubMed

Papassotiropoulos, A., Henke, K., Aerni, A., Coluccia, D., Garcia, E., Wollmer, M. A., et al. (2005). Age-dependent effects of the 5-hydroxytryptamine-2a-receptor polymorphism (His452Tyr) on human memory. NeuroReport, 16, 839–842.PubMed

Papassotiropoulos, A., Stephan, D. A., Huentelman, M. J., Hoerndli, F. J., Craig, D. W., Pearson, J. V., et al. (2006). Common Kibra alleles are associated with human memory performance. Science, 314, 475–478.PubMed

Papassotiropoulos, A., Wollmer, M. A., Aguzzi, A., Hock, C., Nitsch, R. M., & de Quervain, D. J. (2005). The prion gene is associated with human long-term memory. Human Molecular Genetics, 14, 2241–2246.PubMed

Perkins, K. A., Grobe, J. E., Fonte, C., Goettler, J., Caggiula, A. R., Reynolds, W. A., et al. (1994). Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. Journal of Pharmacology and Experimental Therapeutics, 270, 628–638.PubMed

Petrie, R. X., Dreary, U. (1989). Smoking and information processing. Psychopharmacology, 99, 393–396.PubMed

Pezzini, A., Grassi, M., Del Zotto, E., Archetti, S., Spezi, R., Vergani, V., et al. (2005). Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke, 36, 533–539.PubMed

Pezzini, A., Grassi, M., Del Zotto, E., Bazzoli, E., Archetti, S., Assanelli, D., et al. (2004). Synergistic effect of Apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults. Stroke, 35, 438–442.PubMed

Phillips, S., & Fox, P. (1998). An investigation into the effects of nicotine gum on short-term memory. Psychopharmacology, 140, 429–433.PubMed

Pittilo, R. M. (2000). Cigarette smoking, endothelial injury and cardiovascular disease. International Journal of Experimental Pathology, 81, 219–230.

Pomerleau, C. S., Aubin, H. J., & Pomerleau, O. F. (1997). Self-reported alcohol use patterns in a sample of male and female heavy smokers. Journal of Addictive Disorders, 16, 19–24.

Pritchard, W. S., Robinson, J. H., & Guy, T. D. (1992). Enhancement of continuous performance task reaction time by smoking in non-deprived smokers. Psychopharmacology, 108, 437–442.PubMed

Proteggente, A. R., Rota, C., Majewicz, J., Rimbach, G., Minihane, A. M., Kraemer, K., et al. (2006). Cigarette smokers differ in their handling of natural (RRR) and synthetic (all rac) alpha-tocopherol: A biokinetic study in apoE4 male subjects. Free Radicals in Biology and Medicine, 40, 2080–2091.

Qiao, D., Seidler, F. J., & Slotkin, T. A. (2005). Oxidative mechanisms contributing to the developmental neurotoxicity of nicotine and chlorpyrifos. Toxicology and Applied Pharmacology, 206, 17–26.PubMed

Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., et al. (2006). Conversion of mild cognitive impairment to dementia: Predictive role of mild cognitive impairment subtypes and vascular risk factors. Dementia and Geriatric Cognitive Disorders, 21, 51–58.PubMed

Reitz, C., Luchsinger, J., Tang, M.-X., & Mayeux, R. (2005). The effect of smoking and time on cognitive function in the elderly without dementia. Neurology, 65, 870–875.PubMed

Rey, A. (1964). L’examen clinique en psychologie. Paris: Presses Universitaires de France.

Rezvani, A. H., & Levin, E. D. (2001). Cognitive effects of nicotine. Biological Psychiatry, 49, 258–267.PubMed

Richards, M., Jarvis, M. J., Thompson, N., & Wadsworth, M. E. J. (2003). Cigarette smoking and cognitive decline in midlife: Evidence from a prospective birth cohort study. American Journal of Public Health, 93, 994–998.PubMedCrossRef

Richards, M., Strachan, D., Hardy, R., Kuh, D., & Wadsworth, M. (2005). Lung function and cognitive ability in a longitudinal birth cohort study. Psychosomatic Medicine, 67, 602–608.PubMed

Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., et al. (2007). The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nature Genetics, 39, 168–177.PubMed

Roman, G. C. (2005). Vascular dementia prevention: A risk factor analysis. Cerebrovascular Disease, 20(Suppl), 91–100.

Roman, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., et al. (1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS–AIREN International Workshop. Neurology, 43, 250–260.PubMed

Romberger, D. J., Grant, K. (2004). Alcohol consumption and smoking status: The role of smoking cessation. Biomedical Pharmacotherapy, 58, 77–83.

Room, R. (2004). Smoking and drinking as complementary behaviours. Biomedical Pharmacotherapy, 58, 111–115.

Rowland, A. S., & McKinstry, R. C. (2006). Lead toxicity, white matter lesions, and aging. Neurology, 66, 1464–1465.PubMed

Rusted, J. M., & Trawley, S. (2006). Comparable effects of nicotine in smokers and nonsmokers on a prospective memory task. Neuropsychopharmacology, 31, 1545–1549.PubMed

Rytila, P., Rehn, T., Ilumets, H., Rouhos, A., Sovijarvi, A., Myllarniemi, M., et al. (2006). Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD. Respiratory Research, 7, 1–10.

Sabbagh, M. N., Lukas, R. J., Sparks, D. L., & Reid, R. T. (2002). The nicotinic acetylcholine receptor, smoking, and Alzheimer’s disease. Journal of Alzheimer’s Disease, 4, 317–325.PubMed

Sachdev, P. S., Anstey, K. J., Parslow, R. A., Wen, W., Maller, J., Kumar, R., et al. (2006). Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample. Dementia and Geriatric Cognitive Disorders, 21, 300–308.PubMed

Sakuri, Y., & Kanazawa, I. (2002). Acute effects of cigarettes in non-deprived smokers on memory, calculation and executive functions. Human Psychopharmacology Clinical and Experimental, 17, 369–373.

Scherer, G. (2005). Biomonitoring of inhaled complex mixtures—ambient air, diesel exhaust and cigarette smoke. Experimental and Toxicological Pathology, 57, 75–110.

Schick, S., & Glantz, S. (2005). Phillip Morris and toxicological experiments with fresh sidestream smoke: More toxic than mainstream smoke. Tobacco Control, 14, 396–404.PubMed

Shih, R. A., Glass, T. A., Bandeen-Roche, K., Carlson, M. C., Bolla, K. I., Todd, A. C., et al. (2006). Environmental lead exposure and cognitive function in community dwelling older adults. Neurology, 67, 1556–1562.PubMed

Shintani, S., Shiigai, T., & Arinami, T. (1998). Silent lacunar infarction on magnetic resonance imaging MRI: Risk factors. Journal of the Neurological Sciences, 160, 82–86.PubMed

Slotkin, T. A., MacKillop, E. A., Rudder, C. L., Ryde, I. T., Tate, C. A., & Seidler, F. J. (2007). Permanent, sex-selective effects of prenantal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: Indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at 6 months of age. Neuropsychopharmacology, 32, 1082–1097.PubMed

Smith, R. C., Singh, A., Infante, M., Khandat, A., & Kloos, A. (2002). Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology, 27, 479–497.PubMed

Smith, R. C., Warner-Cohen, J., Matute, M., Butler, E., Kelly, E., Vaidhyanathaswamy, S., et al. (2006). Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology, 31, 637–643.PubMed

Soderlund, H., Nilsson, L.-G., Berger, K., Breteler, M. M., Dufouil, C., Fuhrer, R., et al. (2006). Cerebral changes on MRI and cognitive function: The CASCADE study. Neurobiology of Aging, 27, 16–23.PubMed

Spilich, G. J., June, L., & Renner, J. (1992). Cigarette smoking and cognitive performance. British Journal of Addiction, 87, 1313–1326.PubMed

Starr, J. M., Deary, I. J., Fox, H. C., & Whalley, L. J. (2007). Smoking in cognitive change from age 11 to 66 years: A confirmatory investigation. Addictive Behaviors, 32, 63–68.PubMed

Stella, F., Banzato, C. E. M., Se, E. V. G., Scudeler, J. L., Pacheco, J. L., & Kajita, R. T. (2007). Risk factors for vascular dementia in elderly psychiatric outpatients with preserved cognitive functions. Journal of the Neurological Sciences, (in press).

Stewart, W. F., Schwartz, B. S., Davatzikos, C., Shen, D., Liu, D., Wu, X., et al. (2006). Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology, 66, 1476–1484.PubMed

Swan, G. E., Benowitz, N. L., Lessov, C. N., Jacob, P., III, Tyndale, R. F., Wilhelmsen, K. (2005). Nicotine metabolism: The impact of CYP2A6 on estimates of additive genetic influence. Pharmacogenetics and Genomics, 15, 115–125.PubMedCrossRef

Swan, G. E., DeCarli, C., Miller, B. L., Reed, T., Wolf, P. A., & Carmelli, D. (2000). Biobehavioral characteristics of non-demented older adults with subclinical brain atrophy. Neurology, 54, 2108–2114.PubMed

Teng, E. L., Hasegawa, K., Homma, A., Imai, Y., Larson, E., Graves, A., et al. (1994). The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiologic studies of dementia. International Psychogeriatrics, 6, 45–58.PubMed

Tyas, S. L., White, L. R., Petrovitch, H., Ross, G. W., Foley, D. J., Heimovitz, H. K., et al. (2003). Midlife smoking and late life dementia: The Honolulu Asia Aging Study. Neurobiology of Aging, 24, 589–596.PubMed

U.S. Department of Health and Human Services (1989). Reducing the health cunsequences of smoking: 25 years of progress. A report of the surgeon general. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. DHHS Publication No. (CDC) 89-8411.

Van Duijn, C. M., Clayton, D. G., Chandra, V., Fratiglioni, L., Graves, A. B., Heyman, A., et al. (1994). Interaction between genetic and environmental risk factors for Alzheimer’s disease: A reanalysis of case-control studies. Genetic Epidemiology, 11, 539–551.PubMed

Vermeer, S. E., den Heijer, T., Koudstaal, P. J., Oudkerk, M., Hofman, A., & Breteler, M. M. B. (2003). Incidence and risk factors of silent brain infarcts in the population-based Rotterdam scan study. Stroke, 34, 392–396.PubMed

Vermeer, S. E., Koudstaal, P. J., Oudkerk, M., Hofman, A., & Breteler, M. M. B. (2002). Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam scan study. Stroke, 33, 21–25.PubMed

Wang, L., van Belle, G., Kukull, W. B., & Larson, E. B. (2002). Predictors of functional change: A longitudinal study of non-demented people age 65 and older. Journal of the American Geriatrics Society, 50, 1525–1534.PubMed

Weisskopf, M. G., Wright, R. O., Schwartz, J., Spiro, A., III, Sparrow, D., Aro, A., et al. (2004). Cumulative lead exposure and prospective changing in cognition among elderly men: The VA Normative Aging Study. American Journal of Epidemiology, 160, 1184–1193.PubMed

Whalley, L. J., Deary, I. J., Appleton, C. L., & Starr, J. M. (2004). Cognitive reserve and the neurobiology of cognitive aging. Aging Research Reviews, 3, 369–382.PubMed

Whincup, P., Papacosta, O., Lennon, L., & Haines, A. (2006). Carboxyhaemoglobin levels and their determinants in older British men. BMC Public Health, 6, 189.PubMed

Willems, E. W., Rambali, B., Vleeming, W., Opperhuizen, A., van Amsterdam, J. G. C. (2006). Significance of ammonium compounds on nicotine exposure to cigarette smokers. Food and Chemical Toxicology, 44, 678–688.PubMed

Williams, J. M., & Foulds, J. (2007). Successful tobacco dependence treatment in schizophrenia. American Journal of Psychiatry, 164, 222–227.PubMed

Willigendael, E. M., Teijink, J. A., Bartelink, M. L., Kuiken, B. W., Boiten, J., Moll, F. L., et al. (2004). Influence of smoking on incidence and prevalence of peripheral arterial disease. Journal of Vascular Surgery, 40, 1158–1165.PubMed

Wright, C. B., Sacco, R. L., Rundek, T. R., Delman, J. B., Rabbani, L. E., & Elkind, M. S. V. (2006). Interleukin-6 is associated with cognitive function: The Northern Manhattan Study. Journal of Stroke and Cerebrovascular Diseases, 15, 34–38.PubMed

Xu, J., Mendrek, A., Cohen, M. S., Monterosso, J., Simon, S., Jarvik, M., et al. (2007). Effect of cigarette smoking on prefrontal cortical function in nondeprived smokers performing the Stroop Task. Neuropsychopharmacology, 32, 1421–1428.PubMed

Yolton, K., Dietrich, K., Auinger, P., Lanphear, B. P., & Hornung, R. (2005). Exposure to environmental tobacco smoke and cognitive abilities among U.S. children and adolescents. Environmental Health Perspectives, 113, 98–103.PubMedCrossRef

Zdravkovic, T., Genbacev, O., McMaster, M. T., & Fisher, S. J. (2005). The adverse effects of maternal smoking on the human placenta: A review. Placenta, 26 (Supplement A), S81–S86.PubMed

Zhang, X. Y., Tan, Y. L., Zhou, D. F., Haile, C. N., Wu, G. Y., Cao, L. Y., et al. (2007). Nicotine dependence, symptoms and oxidative stress in male patients with schizophrenia. Neuropsychopharmacology, 2007, 1–5.

Titel: The Effects of Tobacco Smoke and Nicotine on Cognition and the Brain
verfasst von: Gary E. Swan
Christina N. Lessov-Schlaggar
Publikationsdatum: 01.09.2007
Verlag: Springer US
Erschienen in: Neuropsychology Review / Ausgabe 3/2007
Print ISSN: 1040-7308
Elektronische ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-007-9035-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2007

Early Detection of Memory Impairment in Alzheimer’s Disease: A Neurocognitive Perspective on Assessment

Neuropsychological Consequences of Opiate Use

The Elusive Nature of Executive Functions: A Review of our Current Understanding

The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment

The Role of Cognitive Control in Cocaine Dependence